Tobacco Use Treatment in Cancer Patients
Implementation Strategies to Improve Tobacco Treatment for UF Health Cancer Center Patients
2 other identifiers
interventional
90
1 country
5
Brief Summary
Tobacco use among cancer survivors reduces the effectiveness of cancer treatments, increases the risk for additional primary cancers, and increases mortality. Implementation of tobacco treatment for cancer patients is challenging, but may be improved substantially with clinically-efficient and sustainable solutions to accurately identify tobacco users, direct them to evidence-based treatment, and provide demonstrable outcomes for stakeholders. At UF Health Cancer Center (UFHCC), patient access and utilization of tobacco use treatment are sub optimal. Further, UFHCC has a largely rural catchment area with a high burden of tobacco-related disease and mortality. To address this research-to-practice gap using a mixed-methods approach to assess the relevant contextual factors at UFHCC and evaluate the feasibility of implementing a multi-level intervention to increase tobacco treatment utilization and improve health outcomes. This study uses a mixed methods approach and will inform the design of a pragmatic clinical trial to improve the delivery of tobacco use treatment services to cancer patients. Guided by a conceptual model that emphasizes patient, provider, and organizational characteristics, the study team will identify factors that influence the implementation process at the UFHCC. The ultimate goal of the proposed research is to provide new knowledge to facilitate the widespread adoption, implementation, and dissemination and sustained utilization of evidence-based tobacco use treatments in cancer care settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started May 2018
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2018
CompletedFirst Posted
Study publicly available on registry
March 29, 2018
CompletedStudy Start
First participant enrolled
May 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedResults Posted
Study results publicly available
May 22, 2020
CompletedMay 22, 2020
May 1, 2020
1.6 years
March 23, 2018
February 11, 2020
May 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Smoking 7-Day Point Prevalence at 12 Weeks
Using intent-to-treat analysis, 3 (7.7%) PhoneQuit, 2 (5.4%) SmartQuit, and 2 (14.3%) GroupQuit patients reported 7-day point prevalence abstinence from smoking. Smart Quit abstinence was verified with CO readings.
12 weeks
Reach
Number of smokers visiting the clinics who are enrolled divided by the total number of smokers visiting the clinics.
12 weeks
Treatment Utilization
Percent of enrolled patient who completed any tobacco-use treatment.
12 weeks
Mean Treatment Acceptability Score
Treatment Acceptability (TAQ) consisted of 16 items scored on a 0 to 10 scale (0=worst, 10=best). The questions assessed aspects of treatment acceptability, such as helpfulness in reducing smoking and thoughts and feelings related to the treatment. Data represents the mean score across all items (range 0-10).
12 weeks
Secondary Outcomes (1)
Change in Cigarettes Smoked Per Day
Baseline to 12 weeks
Study Arms (3)
Cognitive Behavior Therapy with NRT
OTHERCognitive Behavior Therapy (CBT) will be provided by a certified tobacco treatment specialist (CTTS) using vidyo, a HIPAA-compliant video based platform. Participants in this arm, if interested will be provided a 2 week supply of nicotine replacement therapy (NRT). The intervention in this arm would be NRT along with the CBT counseling.
Referral to Area Health Education Center
OTHERThe Area Health Education Center (AHEC) is a locally available tobacco cessation program aimed at strengthening the capacity of Florida's healthcare system to deliver effective evidence based tobacco use treatment, and prevention services throughout the state. The intervention is education on the health effects related to tobacco use, and benefits of quitting and what to expect when quitting. A tobacco cessation specialist of trained facilitator guides participants as they identify triggers and withdrawal symptoms, and discuss ways to cope with them. The program offers free nicotine replacement therapy, educational materials, goodies for their quit day and follow up support.
Referral to Qutiline
OTHERQuitline is a local program in the state where smokers can call a toll free number to talk to coach who can help them quit. There is also an option of online program if they prefer to engage in online help to quit tobacco use. The intervention in this arm is counseling support by phone or online with an option of Nicotine replacement therapy. If participants prefer this option, our nurse will refer them to locally available quitline service using EPIC.
Interventions
Participants in CBT group will also be offered Nicotine Replacement Therapy if they are interested. NRT is the same regimen followed in AHEC and Quitline. In addition, weekly counseling will be provided to the participants remotely via vidyo, a video based platform.
Participants will be referred to local AHEC/Quitline for treatment
Eligibility Criteria
You may qualify if:
- UF Health cancer patients, 18 years and older, who are current smokers.
You may not qualify if:
- Patients with unstable medical or psychiatric illness or
- Patients with a use disorder for illicit drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
UF Ear Nose and Throat (ENT)
Gainesville, Florida, 32611, United States
UF Health at the University of Florida
Gainesville, Florida, 32611, United States
UF Health Medical Oncology
Gainesville, Florida, 32611, United States
UF Health Radiation Oncology
Gainesville, Florida, 32611, United States
University of Florida
Gainesville, Florida, 32611, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Ramzi Salloum, Assistant Professor
- Organization
- University of Florida
Study Officials
- PRINCIPAL INVESTIGATOR
Ramzi G. Salloum, PhD, MBA
University of Florida
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2018
First Posted
March 29, 2018
Study Start
May 14, 2018
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
May 22, 2020
Results First Posted
May 22, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share